CN1057444C - 治疗近视眼药水 - Google Patents

治疗近视眼药水 Download PDF

Info

Publication number
CN1057444C
CN1057444C CN94112074A CN94112074A CN1057444C CN 1057444 C CN1057444 C CN 1057444C CN 94112074 A CN94112074 A CN 94112074A CN 94112074 A CN94112074 A CN 94112074A CN 1057444 C CN1057444 C CN 1057444C
Authority
CN
China
Prior art keywords
myopia
isoproterenol
eye drops
prescription
sodium chloride
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN94112074A
Other languages
English (en)
Other versions
CN1108539A (zh
Inventor
吴生武
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN94112074A priority Critical patent/CN1057444C/zh
Publication of CN1108539A publication Critical patent/CN1108539A/zh
Application granted granted Critical
Publication of CN1057444C publication Critical patent/CN1057444C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Abstract

本发明公开了一种治疗近视眼药水，由尼泊金乙酯，氯化钠，注射用水，加上异丙基肾上腺素，EDTA配制成溶液。能有效地放松睫状肌，解除眼疲劳，经临床试验证明，对治疗假性近视，控制近视度数加深有特效。

Description

治疗近视眼药水
本发明涉及眼的治疗，特别属于近视眼的治疗。
青少年患假性近视及近视眼的人数不少，为了防治近视，发明了各种治疗假性近视和近视的药水，为近视患者的治疗起了一定的作用。例无锡第六制药厂生产的双星明眼药水是一种常用的治疗假性近视和近视的眼药水。它主要由托吡酰胺，尼泊金乙酯配制而成，能起到放松睫状肌的作用，使眼睛有舒服感觉。然而使用此眼药水，也会引起眼睛瞳孔放大，使临床应用受到限制，不能在白天使用，故不能有效地解除眼疲劳。
本发明的目的是提供治疗近视眼药水，它能防止眼睛瞳孔放大，有效地治疗假性近视，控制近视度数的加深。
本发明是这样实现的，它包含有尼泊金乙酯，氯化钠，注射用水所配制，其配方中还加有异丙基肾上腺素和EDTA。
配方中各含量的百分比为异丙基肾上腺素0.005～0.05％，尼泊金乙酯0.03％，氯化钠0.9％，EDTA0.05％，注射用水加到100毫升，相互溶解而成。
本发明由于配方中采用异丙基肾上腺素，使药的作用迅速，能有效地放松睫状肌，且不影响眼睛瞳孔放大。使用方便，昼夜均可应用，有显著的解除眼疲劳作用。
以下将结合配方及实施例对本发明作进一步说明。
治疗近视眼药水的配方为：异丙基肾上腺素0.005～0.05％，它具有迅速有效地放松睫状肌的作用，本实施例异丙基肾上腺素的配方为0.04％。尼泊金乙酯0.03％，以用来防止污染。氯化钠0.9％，能调等渗。EDTA为0.05％，它有抗氧化作用。注射用水加到100毫升，将各配方溶解成溶液就可制成本眼药水。本发明经上海眼病中心防治所临床试验证明，对治疗假性近视，控制近视度数的加深有特效。

Claims (1)

1.治疗近视眼药水，由尼泊金乙酯、氯化钠、注射用水所组成，其特征在于配方中加有异丙基肾上腺素和EDTA，各组分的含量百分比为尼泊金乙酯0.03％、氯化钠0.9％、异丙基肾上腺素0.005-0.05％、EDTA0.05％、注射用水加到100毫升，将各配方溶解成溶液即成。
CN94112074A 1994-03-16 1994-03-16 治疗近视眼药水 Expired - Fee Related CN1057444C (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN94112074A CN1057444C (zh) 1994-03-16 1994-03-16 治疗近视眼药水

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN94112074A CN1057444C (zh) 1994-03-16 1994-03-16 治疗近视眼药水

Publications (2)

Publication Number Publication Date
CN1108539A CN1108539A (zh) 1995-09-20
CN1057444C true CN1057444C (zh) 2000-10-18

Family

ID=5035882

Family Applications (1)

Application Number Title Priority Date Filing Date
CN94112074A Expired - Fee Related CN1057444C (zh) 1994-03-16 1994-03-16 治疗近视眼药水

Country Status (1)

Country Link
CN (1) CN1057444C (zh)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19718826A1 (de) * 1997-05-05 1998-11-12 Marion S Dr Eckmiller Verwendung biologisch aktiver Wirkstoffe zum Beeinflussen des Extrazellulär-Raumes von Sinneszellen und Verfahren zur Wirkstoff-Administrationssteuerung

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1033154A (zh) * 1987-11-20 1989-05-31 李际云 一种眼药水
CN1054718A (zh) * 1990-02-15 1991-09-25 奇诺英药物化学工厂有限公司 眼药水
CN1076113A (zh) * 1992-03-11 1993-09-15 贺茂麟 一种眼药水及其配制

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1033154A (zh) * 1987-11-20 1989-05-31 李际云 一种眼药水
CN1054718A (zh) * 1990-02-15 1991-09-25 奇诺英药物化学工厂有限公司 眼药水
CN1076113A (zh) * 1992-03-11 1993-09-15 贺茂麟 一种眼药水及其配制

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
全中中草药汇编 上册 1973.1.1 *
贵州农村中药制剂，418 1977.1.1 贵州省经品检验所编 *
贵州农村中药制剂，418 1977.1.1 贵州省经品检验所编;全中中草药汇编 上册 1973.1.1 *

Also Published As

Publication number Publication date
CN1108539A (zh) 1995-09-20

Similar Documents

Publication Publication Date Title
MY132626A (en) CARBAZOLYL-SUBSTITUTED ETHANOLAMINES AS SELECTIVE ß-3 AGONISTS
NZ504026A (en) Methods for treating hypercoagulable states or acquired protein C deficiency using human-activated protein C
DE69739792D1 (de) Verfahren zur Behandlung von Augenerkrankungen
CA2285203A1 (en) Compositions containing capsaicin or capsaicin analogues and a local anesthetic
KR920702622A (ko) 안구 발육의 치료 및 조절
CN1057444C (zh) 治疗近视眼药水
Bienenstock et al. Neuroendocrine regulation of mucosal immunity
CA2150183A1 (en) Pharmaceutical composition for the treatment of hemorrhoidal diseases
CA2166155A1 (en) Agents binding to hyaluronic acid binding domains and the use thereof
CA2235951A1 (en) Novel uses of mammalian ctla-8 and related reagents
EP1007093A4 (en) METHODS OF TREATING DISORDERS WITH INTERLEUKIN-9 AND ITS ANTAGONISTS
CA2158173A1 (en) Method of treating addictive behaviors
Favazza Treatment of patients with self-injurious behavior
CN1059322C (zh) 高分子合成材料重睑术用聚丙烯的处理方法
RU95113855A (ru) Способ консервативного лечения ожогов глаз
Jenkins Trigeminal neuralgia: What does the patient need?
KR880002516A (ko) 신경병 치료 및 신경재생을 하여주는 약제 조성물
James NTZ: cryptosporidiosis new treatment
James Major study shows AZT monotherapy inferior
YOSHIKAWA et al. Effect on Intensive Pleoptics of Eccentric Fixation
UA37438A (uk) Спосіб захисту міокарда при інтоксикації
CN1555846A (zh) 银屑速康露
RU93000552A (ru) Лекарственное средство фугентин
RU97106986A (ru) Средство и способ лечения ишемического инсульта
RU94031183A (ru) Способ лечения клинически активного генетального эндометриоза

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee